[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

BeiGene Ltd.

BeiGene faces setbacks in its anti-TIGIT antibody program, leading to negative sentiment. Baillie Gifford exits BeiGene, while the company launches Tevimbra in India.

About BeiGene Ltd.

BeiGene Ltd. is a global oncology company.

Galaxy Score: XX #

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
1-Year High: XX on 2025-03-04
1-Year Low: XX on 2025-07-02

Engagements: XXX #

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXXXX
1 Week: XXXXX -XX%
1 Month: XXXXXX -XX%
6 Months: XXXXXXX -XX%
1 Year: XXXXXXXXX -XX%
1-Year High: XXXXXX on 2024-12-12
1-Year Low: XX on 2025-10-16

Social Network	X	YouTube	News	TikTok
Engagements	XX	XX	X	XXX

Mentions: XX #

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
1 Month: XXX -XX%
6 Months: XXXXX -XX%
1 Year: XXXXX +14%
1-Year High: XXX on 2024-12-13
1-Year Low: XX on 2025-10-14

Social Network	X	YouTube	News	TikTok
Mentions	XX	XX	X	X

Creators: XX #

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning BeiGene Ltd. in the last XX hours which is up XXX% from XX in the previous XX hours Daily Average: XX
1 Month: XX -XX%
6 Months: XXX -XX%
1 Year: XXXXX +67%
1-Year High: XXX on 2025-06-17
1-Year Low: X on 2025-10-14

The most influential creators that mention BeiGene Ltd. in the last XX hours

Creator	Rank	Followers	Posts	Engagements
@beonemedicines	X	XXXXXX	X	XX
@Chemist_Payne	X	XXX	X	XX
@newjerseyheadli	X	XXX	X	X
@ABNewswire	X	XXXXX	X	X
@grok	X	XXXXXXXXX	X	X

Sentiment: XX% #

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XXX% no change
1 Month: XXX% +8%
6 Months: XXX% +28%
1 Year: XXX% +52%
1-Year High: XXX% on 2024-10-18
1-Year Low: XX% on 2025-09-19

Most Supportive Themes

Research and Development: (2%) BeiGene is presenting pioneering cancer research at ASCO 2025.
Financial Performance: (1%) BeiGene's revenue increased, primarily driven by Brukinsa.

Most Critical Themes

Clinical Trial Setbacks: (55%) Concerns about setbacks in the anti-TIGIT antibody program are being discussed.

Network engagement breakdown:

Network	Positive	%	Neutral	%	Negative	%
X	XX	XX%	XX	XX%	X	X%
YouTube	XX	XX%	X	X%	X	X%
News	X	X%	X	X%	X	X%
TikTok	X	X%	XXX	XX%	X	X%

Total	XX	XX%	XXX	XX%	X	X%

Top assets mentioned In the posts about BeiGene Ltd. in the last XX hours

Innovative Solutions & Support (ISSC) AbbVie Inc (ABBV) ImmunityBio, Inc. Common Stock (IBRX) One Cash (ONC) Eli Lilly and Company (LLY) Novartis AG (NVS) AstraZeneca PLC (AZN) Yum China Holdings, Inc. Common Stock (YUMC) Tesla, Inc. (TSLA) Amazon.com, Inc. (AMZN)

Top topics mentioned In the posts about BeiGene Ltd. in the last XX hours

$6160hk, stocks healthcare, china, $1801hk, $issc, $abbv, market cap, tariffs, $9926hk, jersey, fda, $ibrx, future of, $onc, coins stablecoin, investment, eli lilly, novartis, $azn, $novnsw, $150b, $80b, narratives, boston, the only, $13b, half of, stocks, $6753t, has been, team and, asia, sits, $yumc, $0788hk, alibaba, $0981hk, mining, $0631hk, $lkncy, stocks consumer cyclical, stocks technology, tesla, stocks bitcoin treasuries, $amzn, $28b, affordable, $81k, $111kyr, mckesson, $elv, omega, portugal, mucho, oracle, $argx, $akro, $cytk, $fate, $tdoc, $beam, dyne therapeutics, hims hers, $4523t, strategic partnership, $swtx, surge, davis, $38b, $nrix, budgeting, $2269hk, $3692hk